Find cutting edge cancer clinical trials near you using the new Victorian Cancer Trials Link.

Search now

CEC Publications 2002

Breast Cancer

Autier P, Shannoun F, Scharpantgen A, Lux C, Back C, Severi G, Steil S, Hansen-Koenig D. A breast cancer screening programme operating in a liberal health care system: The Luxembourg mammography programme, 1992-1997. Int J Cancer. 2002;97:828-832

Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med. 2002;347:886-894

Spurdle AB, Goodwin B, Hodgson E, Hopper JL, Chen X, Purdie DM, McCredie MR, Giles GG, Chenevix-Trench G, Liddle C. The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics. 2002;12:355-366

Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev. 2002;11:413-416

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G. Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women. Lancet. 2002;360:925-926

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G, Khanna K. No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res. 2002;4:R15

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G. The progesterone receptor exon 4 val660leu g/t polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev. 2002;11:439-443

Thompson D, Szabo CI, Mangion J, et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci U S A. 2002;99:827-831

Colorectal Cancer

Farmer KC, Penfold C, Millar JL, Zalcberg J, McLeish JA, Thomas RJ, Lade S, Thursfield VJ, Giles GG. Rectal cancer in Victoria in 1994: Patterns of reported management. ANZ J Surg. 2002;72:265-270

Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol. 2002;3:83-88

Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, Mead LJ, St John DJ, Macrae FA, Bishop DT, Venter DJ, Giles GG, Hopper JL. After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families. Int J Cancer. 2002;102:166-171

McLeish JA, Thursfield VJ, Giles GG. Survival from colorectal cancer in victoria: 10-year follow up of the 1987 management survey. ANZ J Surg. 2002;72:352-356

Prostate Cancer

Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W, Boyle P, Hopper JL. Androgenetic alopecia and prostate cancer: Findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev. 2002;11:549-553

Other Cancer

Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138:609-614

Giles G. How important are estimates of cancer prevalence? Ann Oncol. 2002;13:815-816

Grossi M, Quinn MA, Thursfield VJ, Francis PA, Rome RM, Planner RS, Giles GG. Ovarian cancer: Patterns of care in Victoria during 1993-1995. Med J Aust. 2002;177:11-16

Menegoz F, Little J, Colonna M, Arslan A, Preston-Martin S, Schlehofer B, Blettner M, Howe GR, Ryan P, Giles GG, Rodvall Y, Choi WN. Contacts with animals and humans as risk factors for adult brain tumours. An international case-control study. Eur J Cancer. 2002;38:696-704

Milne E, Johnston R, Cross D, Giles-Corti B, English DR. Effect of a school-based sun-protection intervention on the development of melanocytic nevi in children. Am J Epidemiol. 2002;155:739-745

Severi G, Cattaruzza MS, Baglietto L, Boniol M, Dore JF, Grivegnee AR, Luther H, Autier P, European Organization for Research Treatment of Cancer Melanoma Cooperative G. Sun exposure and sun protection in young European children: An EORTC multicentric study. Eur J Cancer. 2002;38:820-826

Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer. 2002;101:175-182

Other Conditions

English DR, Vu HT, Knuiman MW. The impact of smoking on use of hospital services: The Busselton Study. Aust N Z J Public Health. 2002;26:225-230

Harrap SB, Wong ZY, Stebbing M, Lamantia A, Bahlo M. Blood pressure QTLS identified by genome-wide linkage analysis and dependence on associated phenotypes. Physiol Genomics. 2002;8:99-105

Yamamoto A, Richie G, Nakamura H, Hosoda S, Nobuyoshi M, Matsuzaki M, Tan CE, Keech A, Mabuchi H, Horibe H, Tenba H, Japan Asmi, Research Committee on Serum Lipid Survey J. Risk factors for coronary heart disease in the Japanese--comparison of the background of patients with acute coronary syndrome in the aspac study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention Study. Journal of atherosclerosis and thrombosis. 2002;9:191-199

Scientific Methods

Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ. 2002;156:69-70

Woods RK, Stoney RM, Ireland PD, Bailey MJ, Raven JM, Thien FC, Walters EH, Abramson MJ. A valid food frequency questionnaire for measuring dietary fish intake. Asia Pac J Clin Nutr. 2002;11:56-61